Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
absent, amortised, ATM, Augmentin, begun, BLA, catastrophic, CDC, cheaper, CJEU, conventional, convey, count, CTA, CTR, Delinquent, derecognized, drew, Eastern, effectuated, explanation, explicitly, expressly, FDORA, FY, gonorrhea, harmonized, HC, imputed, intermittent, IRA, JMI, landscape, legitimize, marker, meant, Memorandum, motion, mycobacterial, Noncompliance, nonpromotional, NTAP, outpace, PBM, prejudice, proactively, propagation, purported, rationale, REASSURE, rental, resold, revoke, Secretary, Shield, short, Signature, subsidy, uninsured, Unitary, UPC
Removed:
addressing, affiliate, allocate, bacteriological, bacteriologically, blinded, blood, cancelled, carcinoma, carryforward, category, clarifying, clinically, composed, computation, Contepo, counterparty, died, disapproval, drawn, elevation, feel, fit, founder, grew, gynecologic, hoc, IHMA, indefinite, Indeterminant, infarction, inflammation, investigator, Japanese, judged, labelling, largely, liver, lung, marking, metastatic, mid, missed, modified, myocardial, Nabriva, nonclinical, nondisruptive, ovarian, point, progression, pyuria, radiologic, readout, redenominated, redenomination, registrational, school, skin, Spero, structured, Surgery, tebipenem, territorial, topline, undrawn, Urology, white
Filing tables
Filing exhibits
Related press release
Associated ITRM transcripts
ITRM similar filings
Filing view
External links
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements Nos. 333-257322, 333-261558, 333-225236, 333-230496, 333-237198, and 333-245655 on Form S-8 and No. 333-267795 on Form S-3 of our report dated March 16, 2023, with respect to the consolidated financial statements of Iterum Therapeutics plc.
/s/ KPMG
Dublin, Ireland
March 16, 2023